3 completed, 2 unknown, 1 suspended, 1 terminated. 4 Phase 4, 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Unknown 2, Suspended 1, Withdrawn 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Nitrendipine: new trials by email Literature Review of Nitrendipine trials Research Report on Nitrendipine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability. Nitrendipine/Atenolol, Nitrendipine, Atenolol - Hypertension | Phase 4 | Unknown | Shanghai Jiao Tong University School of Medicine | 32 | 2021-09-27 | 2023-04-14 |
| Coronavirus (COVID-19) ACEi/ARB Investigation Thiazide or Thiazide-like diuretics, Calcium Channel Blockers, ACE inhibitor - Hypertension, COVID-19 | Phase 4 | Suspended | National University of Ireland, Galway, Ireland | 2414 | 2020-04-30 | 2020-06-30 |
| Treatment of Hypertension in Tibetan Adult Population Nitrendipine, Hydrochlorothiazide, Captopril,Hydrochlorothiazide - Hypertension | Phase 4 | Unknown | West China Hospital | 800 | 2014-08-01 | 2014-08-29 |
| The Standardized Management of Hypertension in Rural Shaanxi Hydrochlorothiazide, Captopril, Nitrendipine, Aspirin - Hypertension | Not applicable | Completed | First Affiliated Hospital Xi'an Jiaotong University | 1210 | 2014-01-01 | 2020-05-01 |
| Sympathetic Nerve Activity in Renal Failure Rilmenidine, Nitrendipine - Chronic Kidney Disease, Hypertension | Phase 4 | Withdrawn | University of Erlangen-Nürnberg Medical School | 2009-11-01 | 2015-03-17 | |
| An Observational Study to Examine the Patients With Isolated Systolic Hypertonia (ISH) Under Therapy With Eneas® (NIS ENEAS ISH) Enalapril maleate (10 mg) + nitrendipine (20 mg) - Hypertension | Completed | Merck KGaA, Darmstadt, Germany | 2065 | 2008-06-01 | 2014-02-19 | |
| Isolated Systolic Hypertension in the Elderly and Very Elderly olmesartan medoxomil + hydrochlorothiazide, if necessary, nitrendipine + hydrochlorothiazide, if necessary - Isolated Systolic Hypertension | Phase 3 | Completed | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 417 | 2003-07-01 | 2023-06-01 |
| Systolic Hypertension in Europe Placebo-Controlled Trial Active treatment with nitrendipine (10-40 mg/day). - Isolated Systolic Hypertension | Phase 2 | Terminated | KU Leuven | 4695 | 1990-02-01 | 2017-05-11 |
Hypertension (6) · Isolated Systolic Hypertension (2) · COVID-19 (1) · Cardiovascular Diseases (1) · Coronavirus Infections (1) · Renal Insufficiency, Chronic (1) · Stroke (1)
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · KU Leuven (1) · Merck KGaA, Darmstadt, Germany (1) · National University of Ireland, Galway, Ireland (1) · Shanghai Jiao Tong University School of Medicine (1) · University of Erlangen-Nürnberg Medical School (1) · West China Hospital (1)
China (3) · Germany (2) · Ireland (1)
Hongyan Tian (1) · Jan A Staessen, MD, PhD (1) · Jiguang Wang, MD, PhD (1) · John William McEvoy, MBBCh MHS (1) · Peter U Witte, MD, Ph.D. (1) · Roland E Schmieder, MD (1) · Xiaoping Chen, MD (1)